Divi's Laboratories Limited Share Price & Analysis
₹6,615.5Updated 5 Jun 2026, 03:30 pm IST
LTP
₹6,615.5
—
Open
₹6,636.5
High
₹6,636.5
Low
₹6,567
Close
₹6,596.5
52W High
₹7,078
52W Low
₹5,636
Volume
201K
Lot Size
100
Sector
Healthcare
Market Cap
₹1.7L Cr
Face Value
₹2
Large CapNIFTY 100NIFTY 200NIFTY 500NEXT 50
Price Chart
Fundamentals
P/E
66.1
Sector P/E
48.9
P/B
10.48
EPS
₹93.38
ROE
16.5%
ROCE
22%
D/E Ratio
0
Div Yield
0.46%
Book Value
₹631
+
Strengths
- ✓Strong return on equity (ROE 16.5%)
- ✓Efficient capital deployment (ROCE 22%)
- ✓Virtually debt-free
−
Concerns
- ✗High premium to book value (P/B 10.5x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
| LUPIN Lupin Limited | ₹2,260 | ₹1.0L Cr | 17.9 | 4.6 | 29.1 | 30.3 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
DIVISLAB · as of Mar 2026
Promoters51.89%
FII18.01%▲0.03
DII20.63%▲0.19
Public9.39%▼0.19
Govt0.09%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 51.92% | 51.92% | 51.89% | 51.89% | 51.89% | 51.89% |
| FII | 14.85% | 14.68% | 16.16% | 17.25% | 17.98% | 18.01% |
| DII | 21.78% | 22.10% | 21.66% | 20.98% | 20.44% | 20.63% |
| Public | 11.33% | 11.19% | 10.17% | 9.79% | 9.58% | 9.39% |
| Govt | 0.10% | 0.10% | 0.10% | 0.09% | 0.09% | 0.09% |
Corporate Events
Dividend - Rs 30 Per Share
Dividend23 Jul 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
Dividend22 May 2026
Dividend - Rs 30 Per Share
Dividend24 Jul 2025
Dividend - Rs 30 Per Share
Dividend1 Aug 2024
Dividend - Rs 30 Per Share
Dividend10 Aug 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2.6K Cr ▼4.1% | ₹2.7K Cr ▲12.7% | ₹2.4K Cr ▼6.8% | ₹2.6K Cr ▲11.5% | ₹2.3K Cr ▼0.8% | ₹2.3K Cr ▲10.4% | ₹2.1K Cr ▼8.0% | ₹2.3K Cr |
| Op. Profit | ₹890 Cr ▲0.2% | ₹888 Cr ▲21.8% | ₹729 Cr ▼17.7% | ₹886 Cr ▲19.2% | ₹743 Cr ▲3.8% | ₹716 Cr ▲15.1% | ₹622 Cr ▼14.9% | ₹731 Cr |
| OPM | 34.0% ▲3.0% | 33.0% ▲10.0% | 30.0% ▼11.8% | 34.0% ▲6.3% | 32.0% ▲3.2% | 31.0% ▲6.9% | 29.0% ▼9.4% | 32.0% |
| Net Profit | ₹583 Cr ▼15.4% | ₹689 Cr ▲26.4% | ₹545 Cr ▼17.7% | ₹662 Cr ▲12.4% | ₹589 Cr ▲15.5% | ₹510 Cr ▲18.6% | ₹430 Cr ▼20.1% | ₹538 Cr |
| EPS (₹) | 21.96 ▼15.4% | 25.95 ▲26.4% | 20.53 ▼17.7% | 24.94 ▲12.4% | 22.19 ▲15.5% | 19.21 ▲18.6% | 16.2 ▼20.1% | 20.27 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹10.6K Cr ▲12.8% | ₹9.4K Cr ▲19.3% | ₹7.8K Cr ▲1.0% | ₹7.8K Cr ▼13.3% | ₹9.0K Cr ▲28.6% | ₹7.0K Cr ▲29.2% | ₹5.4K Cr ▲9.1% | ₹4.9K Cr ▲27.1% | ₹3.9K Cr ▼4.3% | ₹4.1K Cr |
| Expenses | ₹7.1K Cr ▲11.5% | ₹6.4K Cr ▲13.3% | ₹5.6K Cr ▲4.4% | ₹5.4K Cr ▲6.3% | ₹5.1K Cr ▲23.7% | ₹4.1K Cr ▲15.0% | ₹3.6K Cr ▲16.1% | ₹3.1K Cr ▲17.2% | ₹2.6K Cr ▲0.3% | ₹2.6K Cr |
| Op. Profit | ₹3.4K Cr ▲15.7% | ₹3.0K Cr ▲34.5% | ₹2.2K Cr ▼6.8% | ₹2.4K Cr ▼39.0% | ₹3.9K Cr ▲35.5% | ₹2.9K Cr ▲57.0% | ₹1.8K Cr ▼2.6% | ₹1.9K Cr ▲47.7% | ₹1.3K Cr ▼12.5% | ₹1.4K Cr |
| OPM | 33.0% ▲3.1% | 32.0% ▲14.3% | 28.0% ▼9.7% | 31.0% ▼27.9% | 43.0% ▲4.9% | 41.0% ▲20.6% | 34.0% ▼10.5% | 38.0% ▲15.2% | 33.0% ▼8.3% | 36.0% |
| Other Income | ₹433 Cr ▲24.4% | ₹348 Cr ▲3.9% | ₹335 Cr ▼2.6% | ₹344 Cr ▲207.1% | ₹112 Cr ▲96.5% | ₹57 Cr ▼69.4% | ₹186 Cr ▲20.8% | ₹154 Cr ▲43.9% | ₹107 Cr ▲48.6% | ₹72 Cr |
| Interest | ₹23 Cr ▲666.7% | ₹3 Cr ▼25.0% | ₹4 Cr ▲100.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▼71.4% | ₹7 Cr ▲40.0% | ₹5 Cr ▲150.0% | ₹2 Cr ▼33.3% | ₹3 Cr |
| Depreciation | ₹463 Cr ▲15.2% | ₹402 Cr ▲6.3% | ₹378 Cr ▲10.2% | ₹343 Cr ▲9.9% | ₹312 Cr ▲21.9% | ₹256 Cr ▲37.6% | ₹186 Cr ▲10.1% | ₹169 Cr ▲19.0% | ₹142 Cr ▲15.4% | ₹123 Cr |
| PBT | ₹3.4K Cr ▲16.2% | ₹2.9K Cr ▲34.8% | ₹2.2K Cr ▼8.7% | ₹2.4K Cr ▼35.7% | ₹3.7K Cr ▲38.2% | ₹2.7K Cr ▲46.6% | ₹1.8K Cr ▼1.9% | ₹1.9K Cr ▲50.7% | ₹1.2K Cr ▼11.8% | ₹1.4K Cr |
| Tax % | 24.0% ▼4.0% | 25.0% ▼3.8% | 26.0% ▲13.0% | 23.0% ▲15.0% | 20.0% ▼23.1% | 26.0% ▲8.3% | 24.0% ▼11.1% | 27.0% ▼6.9% | 29.0% ▲20.8% | 24.0% |
| Net Profit | ₹2.6K Cr ▲17.2% | ₹2.2K Cr ▲36.9% | ₹1.6K Cr ▼12.2% | ₹1.8K Cr ▼38.4% | ₹3.0K Cr ▲49.2% | ₹2.0K Cr ▲44.1% | ₹1.4K Cr ▲1.8% | ₹1.4K Cr ▲54.3% | ₹877 Cr ▼17.3% | ₹1.1K Cr |
| EPS (₹) | 96.73 ▲17.2% | 82.53 ▲36.9% | 60.27 ▼12.3% | 68.69 ▼38.4% | 111.52 ▲49.2% | 74.75 ▲44.2% | 51.85 ▲1.7% | 50.96 ▲54.2% | 33.04 ▼17.3% | 39.95 |
| Div Payout | 31.0% ▼13.9% | 36.0% ▼28.0% | 50.0% ▲13.6% | 44.0% ▲63.0% | 27.0% ▲0.0% | 27.0% ▼12.9% | 31.0% ▲0.0% | 31.0% ▲3.3% | 30.0% ▲20.0% | 25.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr |
| Reserves | ₹15.4K Cr ▲3.0% | ₹14.9K Cr ▲10.3% | ₹13.5K Cr ▲6.3% | ₹12.7K Cr ▲8.9% | ₹11.7K Cr ▲26.3% | ₹9.2K Cr ▲27.4% | ₹7.3K Cr ▲5.1% | ₹6.9K Cr ▲17.6% | ₹5.9K Cr ▲10.7% | ₹5.3K Cr |
| Borrowings | ₹90 Cr ▲2150.0% | ₹4 Cr ▲33.3% | ₹3 Cr ▲0.0% | ₹3 Cr ▼25.0% | ₹4 Cr ▼20.0% | ₹5 Cr ▼87.2% | ₹39 Cr ▼63.2% | ₹106 Cr ▲68.3% | ₹63 Cr ▲75.0% | ₹36 Cr |
| Other Liabilities | ₹2.6K Cr ▲35.9% | ₹1.9K Cr ▲3.3% | ₹1.9K Cr ▲14.0% | ₹1.7K Cr ▲1.6% | ₹1.6K Cr ▲10.7% | ₹1.5K Cr ▲24.3% | ₹1.2K Cr ▲21.6% | ₹973 Cr ▲22.1% | ₹797 Cr ▲4.6% | ₹762 Cr |
| Total Liabilities | ₹18.2K Cr ▲7.3% | ₹16.9K Cr ▲9.5% | ₹15.5K Cr ▲7.2% | ₹14.4K Cr ▲8.0% | ₹13.4K Cr ▲24.0% | ₹10.8K Cr ▲26.3% | ₹8.5K Cr ▲6.2% | ₹8.0K Cr ▲18.4% | ₹6.8K Cr ▲10.2% | ₹6.2K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹5.7K Cr ▲4.3% | ₹5.4K Cr ▲14.8% | ₹4.7K Cr ▲0.3% | ₹4.7K Cr ▲9.2% | ₹4.3K Cr ▲16.8% | ₹3.7K Cr ▲33.1% | ₹2.8K Cr ▲33.2% | ₹2.1K Cr ▲4.6% | ₹2.0K Cr ▲28.0% | ₹1.6K Cr |
| CWIP | ₹2.0K Cr ▲98.6% | ₹1.0K Cr ▲31.4% | ₹778 Cr ▲267.0% | ₹212 Cr ▼54.9% | ₹470 Cr ▼33.9% | ₹711 Cr ▼22.7% | ₹920 Cr ▲87.0% | ₹492 Cr ▲310.0% | ₹120 Cr ▼73.0% | ₹444 Cr |
| Investments | ₹67 Cr ▲3.1% | ₹65 Cr ▼20.7% | ₹82 Cr ▲6.5% | ₹77 Cr ▲6.9% | ₹72 Cr | ₹0 Cr ▼100.0% | ₹971 Cr ▼50.1% | ₹1.9K Cr ▲3.0% | ₹1.9K Cr ▲15.8% | ₹1.6K Cr |
| Other Assets | ₹10.4K Cr ▼0.2% | ₹10.4K Cr ▲5.4% | ₹9.9K Cr ▲4.8% | ₹9.4K Cr ▲10.8% | ₹8.5K Cr ▲33.6% | ₹6.4K Cr ▲64.7% | ₹3.9K Cr ▲9.9% | ₹3.5K Cr ▲26.3% | ₹2.8K Cr ▲10.3% | ₹2.5K Cr |
| Total Assets | ₹18.2K Cr ▲7.3% | ₹16.9K Cr ▲9.5% | ₹15.5K Cr ▲7.2% | ₹14.4K Cr ▲8.0% | ₹13.4K Cr ▲24.0% | ₹10.8K Cr ▲26.3% | ₹8.5K Cr ▲6.2% | ₹8.0K Cr ▲18.4% | ₹6.8K Cr ▲10.2% | ₹6.2K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹1.7K Cr ▲31.1% | ₹1.3K Cr ▼48.7% | ₹2.5K Cr ▲28.7% | ₹1.9K Cr ▼1.8% | ₹1.9K Cr ▲60.1% | ₹1.2K Cr ▲27.5% | ₹954 Cr ▲22.9% | ₹776 Cr ▼32.5% | ₹1.1K Cr ▲10.8% | ₹1.0K Cr |
| Investing CF | ₹-804 Cr ▼198.9% | ₹-269 Cr ▲90.1% | ₹-2.7K Cr ▼23.4% | ₹-2.2K Cr ▼3026.7% | ₹75 Cr ▲190.4% | ₹-83 Cr ▲87.9% | ₹-685 Cr ▼43.3% | ₹-478 Cr ▲58.1% | ₹-1.1K Cr ▼180.8% | ₹-406 Cr |
| Financing CF | ₹-799 Cr ▲0.0% | ₹-799 Cr ▼0.3% | ₹-797 Cr ▼49.8% | ₹-532 Cr ▼1420.0% | ₹-35 Cr ▲96.8% | ₹-1.1K Cr ▼343.5% | ₹-246 Cr ▲21.7% | ₹-314 Cr ▼15800.0% | ₹2 Cr ▲100.3% | ₹-631 Cr |
| Net Cash Flow | ₹50 Cr ▼74.1% | ₹193 Cr ▲118.5% | ₹-1.0K Cr ▼28.1% | ₹-816 Cr ▼141.1% | ₹2.0K Cr ▲4746.3% | ₹41 Cr ▲78.3% | ₹23 Cr ▲235.3% | ₹-17 Cr ▼230.8% | ₹13 Cr | ₹0 Cr |
| Free Cash Flow | ₹215 Cr ▼16.7% | ₹258 Cr ▼87.0% | ₹2.0K Cr ▲65.7% | ₹1.2K Cr ▲15.6% | ₹1.0K Cr ▲3042.4% | ₹33 Cr ▼85.1% | ₹221 Cr ▼56.0% | ₹502 Cr ▼35.1% | ₹774 Cr ▲20.6% | ₹642 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 106d ▲6.0% | 100d ▲19.0% | 84d ▼15.2% | 99d ▲12.5% | 88d ▼8.3% | 96d ▲11.6% | 86d ▼9.5% | 95d ▲17.3% | 81d ▼4.7% | 85d |
| Inventory Days | 311d ▼14.6% | 364d ▲3.4% | 352d ▲3.2% | 341d ▲3.6% | 329d ▲4.1% | 316d ▼8.9% | 347d ▲10.5% | 314d ▲2.3% | 307d ▲4.8% | 293d |
| Days Payable | 88d ▼6.4% | 94d ▲5.6% | 89d ▼7.3% | 96d ▼17.9% | 117d ▲17.0% | 100d ▲4.2% | 96d ▲0.0% | 96d ▼7.7% | 104d ▲85.7% | 56d |
| Cash Conv. Cycle | 330d ▼10.8% | 370d ▲6.6% | 347d ▲0.9% | 344d ▲14.7% | 300d ▼3.8% | 312d ▼7.1% | 336d ▲7.3% | 313d ▲10.2% | 284d ▼11.8% | 322d |
| Working Capital Days | 192d ▼6.8% | 206d ▲9.6% | 188d ▲6.2% | 177d ▲16.4% | 152d ▼15.6% | 180d ▲6.5% | 169d ▼4.0% | 176d ▲19.7% | 147d ▼7.0% | 158d |
| ROCE | 20.0% ▲25.0% | 16.0% ▼15.8% | 19.0% ▼45.7% | 35.0% ▲9.4% | 32.0% ▲28.0% | 25.0% ▼13.8% | 29.0% ▲31.8% | 22.0% ▼24.1% | 29.0% ▼19.4% | 36.0% |
Source: Screener.in · Lower days = better efficiency
Deep Dive Analysis
About Divi's Laboratories Limited
Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Divi's Laboratories Limited share price today?▾
Divi's Laboratories Limited (DIVISLAB) is currently trading at ₹6,615.5 on NSE, as of the last market session. Prices update daily after market close on MarketNetra.
Is Divi's Laboratories Limited available in F&O (Futures & Options)?▾
Yes, Divi's Laboratories Limited (DIVISLAB) is part of the NSE F&O segment with a lot size of 100 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Divi's Laboratories Limited 52-week high and low?▾
Divi's Laboratories Limited's 52-week high is ₹7,078 and the 52-week low is ₹5,636. The current price of ₹6,615.5 is 6.5% below the 52W high.
What is Divi's Laboratories Limited P/E ratio?▾
Divi's Laboratories Limited's current P/E ratio is 66.1. This indicates the market is paying ₹66.1 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Divi's Laboratories Limited options?▾
Divi's Laboratories Limited options are traded on NSE with monthly expiry contracts (lot size: 100 shares). To trade DIVISLAB options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.